![(PDF) Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial (PDF) Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial](https://i1.rgstatic.net/publication/354697972_Gadoxetic_acid_uptake_as_a_molecular_imaging_biomarker_for_sorafenib_resistance_in_patients_with_hepatocellular_carcinoma_a_post_hoc_analysis_of_the_SORAMIC_trial/links/614888f4a3df59440b9d3638/largepreview.png)
(PDF) Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
![PDF) Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma PDF) Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma](https://i1.rgstatic.net/publication/293045147_Extensive_Use_of_Interventional_Therapies_Improves_Survival_in_Unresectable_or_Recurrent_Intrahepatic_Cholangiocarcinoma/links/56d83c4608aebe4638b44c71/largepreview.png)
PDF) Extensive Use of Interventional Therapies Improves Survival in Unresectable or Recurrent Intrahepatic Cholangiocarcinoma
![Kerstin WOHLGEMUTH | Group Leader Crystallization and Product Design | Dr.-Ing. | Technische Universität Dortmund, Dortmund | TUD Kerstin WOHLGEMUTH | Group Leader Crystallization and Product Design | Dr.-Ing. | Technische Universität Dortmund, Dortmund | TUD](https://i1.rgstatic.net/ii/profile.image/273515220869136-1442222518741_Q512/Kerstin-Wohlgemuth.jpg)